Blood Screening Market Share, Size, Industry Analysis, Trends, Growth and Forecast To 2028

Zion Market Research has published a new report titled "Blood Screening Market By Technology (Rapid Tests, Nucleic Acid Test, Enzyme-Linked Immunosorbent Assay, Next Generation Sequencing, and Western Blot Assay), By Products and Services (Reagents & Kits, Standards & Controls, Buffers, Nucleotides & Solutions, Immunosorbents, Conjugates, Sample Diluents & Wash Solutions, Software & Services, Enzymes & Polymerases, Probes & Primers, Labeling & Detection Reagents, Controls, Substrates, and Instruments), and By End-User (Blood Banks and Hospitals): Global Industry Perspective, Comprehensive Analysis, And Forecast, 2018-2025". According to the report, the global blood screening market was around USD 2,133 million in 2018 and is expected to reach approximately USD 3,989 million by 2025, at a CAGR of around 10.23% between 2019 and 2025.

Blood is a red liquid with suspended proteins and cells and contains white blood cells, red blood cells, and platelets. Blood plays a key role in the transport of oxygen and nutrients to the cells in the entire body. Blood screening is the process of blood examination for a particular disease. The early identification of diseases helps in curing and monitoring diseases. Blood screening is essential for the diagnosis of diseases, such as cancer, HIV (Human Immunodeficiency Virus), etc.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭@https://www.zionmarketresearch.com/sample/blood-screening-market

Rising health expenditure, increasing acceptance of nucleic acid testing, and technological advancements witnessed in the blood screening process are driving the blood screening market growth globally. Initiatives undertaken by various governments and government associations for healthcare are creating new growth opportunities for the global blood screening market. However, compound regulatory frameworks, a shortage of skilled workforce, and the existence of substitute technologies may hamper the global blood screening market growth.

The technology segment of the global blood screening market includes rapid tests, nucleic acid tests, enzyme-linked immunosorbent assays, next-generation sequencing, and western blot assay. The nucleic acid test segment is subdivided into transcription-mediated amplification and real-time polymerase chain reaction. The enzyme-linked immunosorbent assay is bifurcated into platform and generation. On the basis of the platform, the enzyme-linked immunosorbent assay segment is sub-divided into chemiluminescence immunoassay, colorimetric immunoassay, and fluorescence immunoassay.

The next generation segment further includes the first generation, second generation, third generation, fourth generation, and above. On the basis of products and services, the blood screening market is segmented into standards and controls, reagents and kits, buffers, immunosorbents, conjugates, sample diluents and wash solutions, nucleotides and solutions, enzymes and polymerases, software and services, controls, probes and primers, substrates, instruments, and labeling and detection reagents. By end-user, the market includes blood banks and hospitals.

𝐁𝐫𝐨𝐰𝐬𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.zionmarketresearch.com/report/blood-screening-market

By region, North America is projected to lead the blood screening market globally in the future due to various technological advancements made in the blood screening process. The Asia Pacific blood screening market is anticipated to grow at the highest pace over the estimated time period. The European blood screening market is anticipated to show momentous growth due to the increasing number of blood transfusion procedures and complex surgeries performed across the region. The Middle East and Africa and Latin America are projected to show moderate growth in the future.

Some major players operating in the global blood screening market are Grifols, Abbott Laboratories, Thermo Fisher Scientific, Beckman Coulter, Bio-Rad Laboratories, bioMérieux, Ortho Clinical Diagnostics, Siemens Healthineers, Roche Diagnostics, and Becton, Dickinson, and Company.

𝐓𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐬𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐭𝐡𝐞 𝐠𝐥𝐨𝐛𝐚𝐥 𝐛𝐥𝐨𝐨𝐝 𝐬𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐦𝐚𝐫𝐤𝐞𝐭 𝐢𝐧𝐭𝐨:

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐲 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Rapid Tests
Nucleic Acid Test
Enzyme-Linked Immunosorbent Assay
Next Generation Sequencing
Western Blot Assay

𝐈𝐧𝐪𝐮𝐢𝐫𝐞 𝐦𝐨𝐫𝐞 𝐚𝐛𝐨𝐮𝐭 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭@https://www.zionmarketresearch.com/inquiry/blood-screening-market

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐏𝐫𝐨𝐝𝐮𝐜𝐭𝐬 & 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Reagents and Kits
Standards and Controls
Buffers
Nucleotides and Solutions
Immunosorbents
Conjugates
Sample Diluents and Wash Solutions
Software and Services
Enzymes and Polymerases
Probes and Primers
Labeling and Detection Reagents
Controls
Substrates
Instruments

𝐆𝐥𝐨𝐛𝐚𝐥 𝐁𝐥𝐨𝐨𝐝 𝐒𝐜𝐫𝐞𝐞𝐧𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭: 𝐄𝐧𝐝-𝐔𝐬𝐞𝐫 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬

Blood Banks
Hospitals

Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client's needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us-after all-if you do well, a little of the light shines on us.

This release was published on openPR.